Comparable Outcomes and Health-Related Quality of Life for Severe Aplastic Anemia: Haploidentical Combined With a Single Cord Blood Unit <i>vs</i> Matched Related Transplants.

Front Oncol · 2021 · PMC8804318 · PMID 35117985

Europe PMC DOI

hedged sentence

0.1330

closest p · 2.7× alpha

0.1330

boldest claim

The sentences

did not reach statistical significanceP = 0.133not close (p > 0.1)

Among patient less than 40 years of age, OS and GFFS tended to be better in the Haplo-cord HSCT group (n = 67) compared with the MRD-HSCT group (n = 68), although it did not reach statistical significance (OS: 83.6 ± 4.5% vs 72.0 ± 5.5%%; P = 0.133; and GFFS: 77.5 ± 5.1% vs 64.6 ± 5.8%; P = 0.127) ( Figures 2C and 3C .

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.